x
Loading
+ -

University of Basel

26 November 2015

Antibody-Drug Compounds and Immunotherapy to Treat Breast Cancer

To more efficiently treat breast cancer, scientists have been researching molecules that selectively bind to cancer cells and deliver a substance that can kill the tumor cells, for several years. Researchers from the University and University Hospital Basel have now for the first time successfully combined such an antibody-drug conjugate with a therapy that stimulates the immune system to attack tumor cells. This opens the door to new therapeutic options in the treatment of breast cancer, report the researchers in the scientific journal Science Translational Medicine.

Thematic focal area

Immunotherapy – A revolution in cancer treatment.

more
To top